FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321814730> ?p ?o ?g. }

• W2321814730 abstract "Upon successful chemotherapy, cancer cells undergo either apoptosis or senescence. Whereas the mechanism of cancer cell apoptosis is relatively well understood, there is only scant knowledge on how chemotherapy-induced cancer senescence occurs. Here we report that a cascade of secreted proteins, plasminogen activator inhibitor 1 (PAI-1) — tissue-type plasminogen activator (t-PA) — insulin-like growth factor-binding protein 3 (IGFBP3), mediates chemotherapy-induced senescence of breast cancer cells. MCF-7 breast cancer cells display robust senescence induction upon doxorubicin treatment and we found that the conditioned medium from senescent MCF-7 cells can induce senescence in non-senescent MCF-7 cells, which suggested the presence of secreted mediator(s) of senescence. To identify such mediator(s), we undertook a quantitative proteomic analysis of the protein secretion from senescent MCF-7 cells and observed significantly increased levels of secreted IGFBP3. Increased extracellular IGFBP3 levels were also observed upon doxorubicin-induced senescence of ZR75-1 breast cancer cells and primary mammary epithelial cells. We demonstrated that IGFBP3 induces senescence in breast cancer cells, which requires the Rb and p53 pathways. Conversely, shRNA-mediated knock-down of IGFBP3 alleviated doxorubicin-induced senescence of breast cancer cells. These results suggest that IGFBP3 functions as secreted mediator of chemotherapy-induced breast cancer senescence. To gain insight into the regulation of IGFBP3-induced senescence, we undertook a proteomic screening for IGFBP3 interactor(s) in the secretome and identified t-PA as candidate interactor. t-PA is a secreted protease that is known to cleave and activate plasminogen. We found that t-PA cleaves IGFBP3 and abolishes IGFBP3-induced or doxorubicin-induced senescence of breast cancer cells. The protease activity of t-PA toward plasminogen is inhibited by PAI-1 and we demonstrated that PAI-1 also protects IGFBP3 from cleavage by t-PA. Interestingly, PAI-1 was previously identified as an inducer of senescence that acts downstream of p53 (Nature Cell Biology 8:877–84, 2006). We showed that IGFBP3 knock-down by shRNAs abolishes senescence induction by PAI-1, suggesting that IGFBP3 is a critical downstream mediator of PAI-1-induced senescence. We also observed dramatically increased extracellular PAI-1 levels upon doxorubicin-induced senescence of breast cancer cells. Importantly, RNAi suppression of PAI-1 in breast cancer cells resulted in concomitant suppression of extracellular IGFBP3 levels upon doxorubicin treatment and abrogation of senescence induction. Taken together, these results suggest a role for extracellular PAI-1 — t-PA — IGFBP3 cascade in mediating chemotherapy-induced senescence of breast cancer cells. This study uncovered the extracellular components of senescence signaling for chemotherapy-treated breast cancer cells. Senescence mediators secreted from chemotherapy-treated breast cancer cells may amplify the senescence response and provide a non-cell autonomous tumor suppression mechanism. These extracellular senescence mediators could be exploited to increase the efficacy of breast cancer chemotherapy. Citation Information: Cancer Res 2011;71(24 Suppl):Abstract nr P2-04-01." @default.
• W2321814730 created "2016-06-24" @default.
• W2321814730 creator A5012596227 @default.
• W2321814730 creator A5040124427 @default.
• W2321814730 creator A5061402512 @default.
• W2321814730 creator A5067680881 @default.
• W2321814730 creator A5087186539 @default.
• W2321814730 date "2011-12-15" @default.
• W2321814730 modified "2023-09-27" @default.
• W2321814730 title "P2-04-01: Extracellular PAI-1 – t-PA – IGFBP3 Cascade Mediates Chemotherapy-Induced Senescence of Breast Cancer Cells." @default.
• W2321814730 doi "https://doi.org/10.1158/0008-5472.sabcs11-p2-04-01" @default.
• W2321814730 hasPublicationYear "2011" @default.
• W2321814730 type Work @default.
• W2321814730 sameAs 2321814730 @default.
• W2321814730 citedByCount "0" @default.
• W2321814730 crossrefType "proceedings-article" @default.
• W2321814730 hasAuthorship W2321814730A5012596227 @default.
• W2321814730 hasAuthorship W2321814730A5040124427 @default.
• W2321814730 hasAuthorship W2321814730A5061402512 @default.
• W2321814730 hasAuthorship W2321814730A5067680881 @default.
• W2321814730 hasAuthorship W2321814730A5087186539 @default.
• W2321814730 hasConcept C121608353 @default.
• W2321814730 hasConcept C134018914 @default.
• W2321814730 hasConcept C170493617 @default.
• W2321814730 hasConcept C190283241 @default.
• W2321814730 hasConcept C2775960820 @default.
• W2321814730 hasConcept C2776694085 @default.
• W2321814730 hasConcept C2778279177 @default.
• W2321814730 hasConcept C2779679481 @default.
• W2321814730 hasConcept C2781303535 @default.
• W2321814730 hasConcept C502942594 @default.
• W2321814730 hasConcept C522857546 @default.
• W2321814730 hasConcept C530470458 @default.
• W2321814730 hasConcept C54355233 @default.
• W2321814730 hasConcept C55493867 @default.
• W2321814730 hasConcept C86803240 @default.
• W2321814730 hasConcept C88045685 @default.
• W2321814730 hasConcept C95444343 @default.
• W2321814730 hasConcept C96232424 @default.
• W2321814730 hasConceptScore W2321814730C121608353 @default.
• W2321814730 hasConceptScore W2321814730C134018914 @default.
• W2321814730 hasConceptScore W2321814730C170493617 @default.
• W2321814730 hasConceptScore W2321814730C190283241 @default.
• W2321814730 hasConceptScore W2321814730C2775960820 @default.
• W2321814730 hasConceptScore W2321814730C2776694085 @default.
• W2321814730 hasConceptScore W2321814730C2778279177 @default.
• W2321814730 hasConceptScore W2321814730C2779679481 @default.
• W2321814730 hasConceptScore W2321814730C2781303535 @default.
• W2321814730 hasConceptScore W2321814730C502942594 @default.
• W2321814730 hasConceptScore W2321814730C522857546 @default.
• W2321814730 hasConceptScore W2321814730C530470458 @default.
• W2321814730 hasConceptScore W2321814730C54355233 @default.
• W2321814730 hasConceptScore W2321814730C55493867 @default.
• W2321814730 hasConceptScore W2321814730C86803240 @default.
• W2321814730 hasConceptScore W2321814730C88045685 @default.
• W2321814730 hasConceptScore W2321814730C95444343 @default.
• W2321814730 hasConceptScore W2321814730C96232424 @default.
• W2321814730 hasLocation W23218147301 @default.
• W2321814730 hasOpenAccess W2321814730 @default.
• W2321814730 hasPrimaryLocation W23218147301 @default.
• W2321814730 hasRelatedWork W1829383288 @default.
• W2321814730 hasRelatedWork W1859313465 @default.
• W2321814730 hasRelatedWork W1970517061 @default.
• W2321814730 hasRelatedWork W1983122048 @default.
• W2321814730 hasRelatedWork W1996105260 @default.
• W2321814730 hasRelatedWork W2000258062 @default.
• W2321814730 hasRelatedWork W2024349962 @default.
• W2321814730 hasRelatedWork W2086111949 @default.
• W2321814730 hasRelatedWork W2224696370 @default.
• W2321814730 hasRelatedWork W2429050223 @default.
• W2321814730 hasRelatedWork W2802173909 @default.
• W2321814730 hasRelatedWork W2883745374 @default.
• W2321814730 hasRelatedWork W2976837897 @default.
• W2321814730 hasRelatedWork W2998900712 @default.
• W2321814730 hasRelatedWork W3037136350 @default.
• W2321814730 hasRelatedWork W3042010163 @default.
• W2321814730 hasRelatedWork W3119325830 @default.
• W2321814730 hasRelatedWork W3156154563 @default.
• W2321814730 hasRelatedWork W3167312592 @default.
• W2321814730 hasRelatedWork W657379961 @default.
• W2321814730 isParatext "false" @default.
• W2321814730 isRetracted "false" @default.
• W2321814730 magId "2321814730" @default.
• W2321814730 workType "article" @default.